Navigation Links
ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin

Speculation that the Food and Drug Administration will give a nod for the generic version of Vancocin caused shares in ViroPharma to dip by about 33 percent. The rumors of the FDA's changed perspective // strengthened after Laura Alvey, a spokeswoman for the F.D.A said in an e-mail message that the agency had "recently revised the bioequivalence recommendations for oral vancomycin from a clinical trial with bioequivalence endpoints to an in vitro method involving dissolution testing."

Vancocin or vancomycin is used exclusively to treat hospital-acquired bacterial infections caused in the lower digestive tract by the bacterium Clostridium difficile. Basically, the FDA's changed stance means that a clinical trial for generic vancomycin might not be necessary if it dissolves at the same rate as Vancocin. ViroPharma has intimated that it has filed a petition to stay the action with the F.D.A and added that it would file many more petitions to support "vigorous opposition to any approach that does not require rigorous scientific methods to demonstrate a rate and extent of drug release to the site of action consistent with good medicine and science." But analysts at Infinium Capital feel that a generic version of Vancocin could be available by early 2008. "Previously, generic manufacturers may not have been interested in developing this therapeutic due to its low revenue potential; however, with the recent sales growth of 133 percent in 2005, Vancocin is now on the radar screen," an analyst at Infinium Capital, Bernadine Leung, said.
'"/>




Page: 1

Related medicine news :

1. Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail
2. Sun Pharma Allots Shares Upon Fccbs Conversion
3. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
4. FDA Moves In To Check Listeria
5. Genetic Test for Type II Diabetes Moves Closer
6. Inhaled Insulin Study Moves Ahead
7. Looking Towards More Effective Leukemia Treatment
8. Attitude Towards AIDS Patients – Time For A Change
9. Scientists Awarded Appropriately For Contribution Towards Medical Research
10. A Step Towards Unraveling The Schizophrenia And Depression Mystery
11. Are Women Not Hearty Enough Towards Seeking Heart Care?
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ViroPharma Shares Fall FDA Moves Towards Generic Vancocin

(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... From ... 86 children and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at ... staff included 65 adult counselors, some of whom work for Calvary, and two junior ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... options to efficiently cure and prevent different malignancies. Some options for cancer ... pathophysiological properties due to which distinctive approach is necessary for effective treatment. ...
(Date:9/1/2015)... ... 2015 , ... Negative pressure wound therapy (NPWT) entails the ... exudates, fluid, and infectious materials to prepare the wound for healing and closure. ... canisters, etc.) is projected to expand continuously through 2021. , Rising patient and ...
(Date:9/1/2015)... Florida (PRWEB) , ... September ... ... of Professional Background Screeners (NAPBS®) has announced that Edge Information Management ... conducted by the Background Screening Credentialing Council (BSCC). , “Achieving and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a leading global ... that it has hired Scott Sanderson, an experienced business development professional and former ... be responsible for establishing and managing new client relationships in the Southeast U.S. ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2
... July 31 With the world,s,attention focused on ... Miracles -- a 30-minute Sunday morning public affairs ... of real,patients -- will feature two of America,s ... Jenner. Sharing Miracles now shows on 158,television stations ...
... VANCOUVER, July 31 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) announced ... in Arlington Virginia. This Center is the Company,s first ... markets that CRH has targeted for,expansion. The opening of ... bringing the Company,s total number of Centers to 17., ...
... July 31 The American Association,of PPOs (AAPPO) ... course",for PPO executives on strategies to improve the ... AAPPO Adding Value Initiative will inform AAPPO,members and ... outcomes., (Logo: http://www.newscom.com/cgi-bin/prnh/20060126/CLTH062LOGO ), ...
... Policies Needed, WASHINGTON, July 31 As the ... convening of the,International AIDS Conference in Mexico City, the ... to announce on August 3rd,significantly higher HIV incidence numbers ... infections per year; the new number may be,more than ...
... number of unusual chromosomal changes, particularly structural changes that ... genes. These results were published today in the scientific ... in the structure of the genes in patients with ... number variants. Genetic diseases are caused by a large ...
... an increased risk of developing cardiovascular disease, particularly stroke ... Atherosclerosis , has now led to attempts to ... (hardening of the arteries) is an inflammatory disease in ... and become less elastic. It can cause blood clots ...
Cached Medicine News:Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 2Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 3Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 4Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 5Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 6Health News:CRH Medical Corporation opens center in Virginia 2Health News:AAPPO Launches Short Course Conference Call Series on Value-added Strategies for PPOs 2Health News:Higher Number of HIV Infections Must Translate Into Leadership & Action by U.S. Government 2Health News:Unusual chromosomal changes increase the risk of schizophrenia 2Health News:New discovery may lead to immunization against cardiovascular disease 2
(Date:9/1/2015)... IRVINE, Calif. , Sept. 1, 2015  Edwards ... in the science of heart valves and hemodynamic monitoring, ... Fargo Healthcare Conference at the Hyatt Regency Boston in ... 9, 2015. Michael A. Mussallem , ... keynote lunch speaker followed by a company discussion with ...
(Date:9/1/2015)... Taiwan,s GNT Biotech ... Taipei on  August 25 th ... a targeted drug delivery technology that uses nano-scale gold ... part of a joint press conference held by its ... showcasing GNT,s latest edible gold-based food and beverage partners, ...
(Date:9/1/2015)... DIEGO , Sept. 1, 2015 Agena Bioscience ... Shanghai , a commercial and financial hub ... growing number of genomic testing laboratories in mainland ... significant portion of Agena Bioscience,s global sales with almost sixty ... China will allow us to expand ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Agena Bioscience Opens Office in Shanghai, China 2
... Jan. 17, 2012 ULURU Inc. (NYSE AMEX: ... previously announced European license for Altrazeal® to include the Middle ... extension of the territory, Helmut Kerschbaumer Chairman of Melmed Holdings ... has experience marketing to the various sectors in these markets. ...
... Incisive Surgical, Inc. today announced a peer-reviewed ... titled "Skin Closure With Subcuticular Absorbable Staples After ... was published online by the Archives of Gynecology ... Drs. Joshua Nitsche (Mayo Clinic College of Medicine, ...
Cached Medicine Technology:ULURU Inc. Extends the European Altrazeal® License to Include the Middle East and Africa 2Incisive Surgical Announces Breakthrough Peer Review Clinical Study 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: